|
|
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study
Stefano Kim
,
Eric François
,
Thierry André
,
Emmanuelle Samalin
,
Marine Jary
et al.
Article dans une revue
hal-01863908v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer
Emeric Boisteau
,
Eric François
,
Thomas Aparicio
,
Karine Le Malicot
,
Rabia Boulahssass
et al.
Article dans une revue
hal-03632563v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Phase III randomized trial comparing 5-fluorouracil and oxaliplatin with or without docetaxel in first-line advanced gastric cancer chemotherapy (GASTFOX study)
Aziz Zaanan
,
Emmanuelle Samalin
,
Thomas Aparicio
,
Olivier Bouché
,
Pierre Laurent-Puig
et al.
Article dans une revue
hal-01917535v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO)
Christophe Locher
,
Blaise Batumona
,
Pauline Afchain
,
Nicolas Carrère
,
Emmanuelle Samalin
et al.
Article dans une revue
hal-01708040v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects
Simon Pernot
,
Cecile Badoual
,
Magali Terme
,
Florence Castan
,
Aurelie Cazes
et al.
Article dans une revue
hal-01579145v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|